Atlas Trials

A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.

Clinical trial NCT00437606 · TERMINATED

Trial details

NCT number
NCT00437606
Sponsor
Hoffmann-La Roche
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2007-03-01
Primary completion
2007-06-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.